Live feed07:00:00·1172dPRReleasevia QuantisnowConcert Pharmaceuticals Maintains Deuruxolitinib Breakthrough Therapy Designation from FDA for the Treatment of Alopecia AreataByQuantisnow·Wall Street's wire, on your screen.CNCE· Concert Pharmaceuticals Inc.Health Care
